Australia has one of the highest incidences of IBD worldwide
Inflammatory Bowel Disease (IBD) affects 1 in every 250 Australians, resulting in over 80,000 people. Being such a large issue that impacts so many in our community, it is clear that more investigation into the connection between IBD and the gut microbiome is vital.
“Using our advanced DNA sequencing approach, we are able to discover novel species which we believe are playing a role in IBD.”
– Professor Gene Tyson, Co-founder of Microba
We want to make a difference.
The aim of our Future Insights IBD Research Program is to investigate the gut microbiome’s potential involvement in the onset of Crohn’s Disease and Ulcerative colitis, ultimately leading to future therapeutics derived from the gut microbiome.
Explore Future Insights
Inflammatory bowel disease: could your microbiome be involved?
Emerging evidence suggests the gut microbiome may play a role in triggering the onset of IBD, such as Ulcerative colitis and Crohn’s disease. READ MORE …